6609.Hk
The company operates in the medical equipment, supplies, and distribution industry, generating revenue primarily through the sale and distribution of medical products and services.
Business. The company operates in the medical equipment, supplies, and distribution industry, generating revenue primarily through the sale and distribution of medical products and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the medical equipment, supplies, and distribution industry, generating revenue primarily through the sale and distribution of medical products and services.
The company maintains a strong liquidity position, with a current ratio of 11.49, indicating a significant buffer of current assets over current liabilities. Its cash and equivalents amount to 456,074,000 CNY, which supports operational flexibility and short-term obligations. The debt-to-equity ratio is 0.04, suggesting a conservative capital structure with minimal reliance on debt financing.
Profitability metrics show a return on equity (ROE) of 7.36% and a return on assets (ROA) of 6.45%, which are indicative of efficient use of equity and assets to generate returns. The net income of 83,335,000 CNY and operating income of 88,470,000 CNY reflect solid operational performance. Gross profit of 289,521,000 CNY supports a healthy margin structure, although the exact comparison to industry medians is not available in the provided data.
The company's revenue is concentrated within the healthcare services and equipment sector, with no disclosed geographic diversification or segment breakdown. This lack of segment detail limits the ability to assess geographic or product-specific exposure.
The company's growth trajectory is not explicitly outlined in the provided data, but the operating cash flow of 154,141,000 CNY and free cash flow of 97,458,000 CNY suggest a capacity for reinvestment or shareholder returns. Capital expenditures of -14,165,000 CNY indicate a net reduction in capital spending, which may reflect a focus on maintaining rather than expanding physical assets.
Risk factors are assessed as low for both liquidity and dilution, with no immediate filing-based flags detected. The low dilution risk is supported by the absence of significant changes in shares outstanding between basic and diluted figures. The company's conservative leverage and strong liquidity position further mitigate financial risk.
Recent events, including analyst estimates and filings, indicate a last actual EPS of -2.47 CNY and a last actual revenue of 232,344,000 CNY. These figures suggest a recent earnings challenge, though the broader financial snapshot indicates a generally stable and profitable operation.
- The company maintains a strong liquidity position with a current ratio of 11.49 and significant cash reserves.
- Profitability metrics, including ROE and ROA, indicate efficient use of equity and assets.
- The company's capital structure is conservative, with a low debt-to-equity ratio of 0.04.
- No immediate liquidity or dilution risks are identified, and the company's financial position appears stable.
- The company's recent earnings performance shows a negative EPS, but overall financial health remains robust.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 6609.HK Market data — financials · 2026-05-27
- Shanghai HeartCare Medical Technology Corp Ltd Market data — analyst estimates · 2026-05-27